Scivita Medical’s 3D Visualization System has made a major breakthrough in the clinical application

Recently, the research paper "Effect of three-dimensional imaging device on polyp and adenoma detection during colonoscopy: a randomized controlled trial" by Professor Zhang Shutian's team of Beijing Friendship Hospital affiliated to Capital Medical University was published in the internationally renowned journal "AMERICAN JOURNAL OF GASTROENTEROLOGY", the official journal of the American College of Gastroenterology (Chinese Academy of Gastroenterology District 1). This paper describes that the use of domestic 3D imaging technology from Scivita Medical in colonoscopy improves the polyp detection rate (PDR) and adenoma detection rate (ADR). The polyp detection rate (PDR) increased by 1.54 times, and the adenoma detection rate (ADR) increased by 1.45 times.

Link to the paper:

https://journals.lww.com/ajg/Abstract/9900/Effect_of_three_dimensional_imaging_device_on.801.aspx 

Conventional 2D colonoscopy provides a flat, two-dimensional image. In contrast, 3D stereoscopic imaging offers several advantages. Firstly, it enables doctors to identify lesions or suspected lesions with greater ease, thereby reducing the risk of missed diagnoses. By presenting the gastric mucosa and intestinal wall with their subtle concavities and convexities in three dimensions, 3D imaging assists doctors in making more accurate judgments regarding the nature of the lesions. It enhances the operator's sense of positional relationships by increasing motion parallax and creating a stereo perception. This improvement in spatial perception is particularly valuable during procedures such as endoscopic submucosal dissection (ESD), where precise mucosal layering is crucial for safer and more accurate separations and incisions. Consequently, the use of 3D imaging reduces the risk of complications such as bleeding and perforation. Additionally, the enhanced spatial positioning provided by 3D imaging improves surgical efficiency and reduces the overall treatment duration.

To substantiate the clinical advantages of this technology, Prof. Zhang Shutian and his team at Beijing Friendship Hospital undertook a single-blind, randomized, controlled trial titled "The Effect of 3D Imaging Devices on the Detection of Polyps and Adenomas in Colonoscopy," utilizing Scivita Medical's 3D Visualization System. The trial involved the consecutive recruitment of participants aged between 18 and 70 years who underwent diagnostic or screening colonoscopies. The recruitment period spanned from August 2019 to May 2022. In the study, participants were randomly assigned in a 1:1 ratio to undergo either a 2D-3D colonoscopy or a 3D-2D colonoscopy using a computer-generated random number. The study's primary endpoints were the polyp detection rate (PDR) and adenoma detection rate (ADR), where ADR refers to the proportion of individuals with at least one polyp or adenoma detected during colonoscopy. In conclusion, the study demonstrated that 3D visualization system can improve the polyp detection rate (PDR) and adenoma detection rate (ADR) during colonoscopy procedures. These devices were particularly beneficial for intermediate and junior endoscopists.

Scivita Medical’s 3D Visualization System initially creates 2D to 3D function, which can be adapted for specialized endoscopes used in various clinical departments, especially small mirrors and soft mirrors: such as digestive scope, cystoscopy, hysteroscopy, nasal endoscope and biliary scope, etc., the original 2D image can be converted into natural 3D image in real time and the picture quality is improved synchronously, and surgeons are able to visualize the precise location of vessels or veins and other structures during the operation, thus the probability of bleeding is greatly reduced; It can strengthen the sense of depth and layering , and avoid the damage to the surrounding organs; In a narrow space, the 3D picture can enlarge the sense of surgical space and improve the accuracy of surgery; At the same time, the product also supports 3D broadcasting of real-time surgery, which can be applied to medical education and training, greatly shortening the learning curve of endoscopy.

Founded in 2016, Scivita Medical is a medical device company that provides minimally invasive diagnosis and treatment solutions, and focuses on the research, development and commercialization of medical endoscopes and related products. Scivita Medical takes ‘Based in China, Faces the World’ as its core strategy and has established R&D centers both in China and Japan. With solid in-house R&D capabilities, Scivita Medical has established a unique technology platform built upon five synergistic core technologies, and built a comprehensive portfolio of endoscope products and products candidates covering all types of endoscope procedures conducted by the various clinical departments, to address diverse medical needs. Adhering its value of ‘Clinical Focus’ ‘Collaborative Innovation’ ‘People Oriented’ ‘High Performance’, Scivita Medical will continuously upgrade its core technologies, improve market penetration with excellent products, and to be the preferred brand trusted by doctors and patients around the world.